Amedisys (AMED) Misses Q4 EPS by 10c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Salaries and benefits: 77.02M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Salaries and benefits: 77.02M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q4 EPS of $0.96, $0.10 worse than the analyst estimate of $1.06. Revenue for the quarter came in at $598.1 million versus the consensus estimate of $596.76 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- Sphere 3D prices $5M private placement, sells Iowa site and mining fleet
- StoneX Starts Aptiv PLC. (APTV) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
